Study Confirms that Frequency of Source Plasma Donation as Regulated by U.S. FDA Does Not Impair Donor Health and Well-Being

ANNAPOLIS, Md., Aug. 25, 2023 /PRNewswire/ — The Plasma Protein Therapeutics Association (PPTA) announced the publication of its research study assessing the “Effects of Donation Frequency on U.S. Source Plasma Donor Health” in the Transfusion journal. The results of this peer-reviewed…